Semaglutide, a GLP-1 receptor agonist approved by the FDA for type 2 diabetes and chronic weight management, has important effects on liver enzymes that clinicians and patients should understand
Washing packed red blood cells decreases red blood cell storage lesion formation
Rybelsus can drastically reduce Pill Burden, with its simple, once-daily dosage that sidesteps the drive-thru dash for refills
Helps Boost Muscle Growth: By enhancing the metabolism of fats into energy, L-Carnitine helps in increasing muscle growth and improving physical performance during workouts
Wegovy / Ozempic Weekly Injection Schedule Note: Wegovy (weight management) and Ozempic (type 2 diabetes) both contain semaglutide and share the same escalation through 1.0 mg
Beneficiaries with Part D benefits can qualify for discounted GLP-1 coverage by meeting one of the following requirements: Group 1 : Overweight individuals with a Body Mass Index (BMI) greater than 27, individuals with prediabetes or have had a heart attack, stroke or blocked arteries in your legs or arms Group 2 : Overweight individuals with a BMI greater than 30, individuals with certain types of heart failure, high blood pressure thats hard to control, or chronic kidney disease (stage 3a or above) Group 3 : Overweight individuals with a BMI greater than 35